Bristol-Myers Squibb Company

Bristol-Myers Squibb Companyverified

BMY

Price:

$41.24

Market Cap:

$83.60B

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphi...[Read more]

Industry

Drug Manufacturers - General

IPO Date

1972-06-01

Stock Exchange

NYSE

Ticker

BMY

The PE Ratio as of May 2024 (TTM) for Bristol-Myers Squibb Company (BMY) is -13.30

According to Bristol-Myers Squibb Company’s latest financial reports and current stock price. The company's current PE Ratio is -13.30. This represents a change of -220.55% compared to the average of 11.03 of the last 4 quarters.

Bristol-Myers Squibb Company (BMY) Historical PE Ratio (quarterly & annually)

How has BMY PE Ratio performed in the past?

The mean historical PE Ratio of Bristol-Myers Squibb Company over the last ten years is 33.21. The current -13.30 PE Ratio has changed -4105.06% with respect to the historical average. Over the past ten years (40 quarters), BMY's PE Ratio was at its highest in in the December 2014 quarter at 1.88K. The PE Ratio was at its lowest in in the June 2020 quarter at -391.37.

Quarterly (TTM)
Annual

Average

33.21

Median

23.07

Minimum

-15.57

Maximum

100.10

Bristol-Myers Squibb Company (BMY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bristol-Myers Squibb Company PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 356.89%

Maximum Annual PE Ratio = 100.10

Minimum Annual Increase = -227.16%

Minimum Annual PE Ratio = -15.57

Quarterly (TTM)
Annual
YearPE RatioChange
202313.23-45.39%
202224.2222.34%
202119.80-227.16%
2020-15.57-148.93%
201931.8285.66%
201817.14-82.88%
2017100.10356.89%
201621.91-68.97%
201570.6144.67%
201448.8143.17%

Bristol-Myers Squibb Company (BMY) Average PE Ratio

How has BMY PE Ratio performed in the past?

The current PE Ratio of Bristol-Myers Squibb Company (BMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

19.08

5-year avg

14.70

10-year avg

33.21

Bristol-Myers Squibb Company (BMY) PE Ratio vs. Peers

How is BMY’s PE Ratio compared to its peers?

Bristol-Myers Squibb Company’s PE Ratio is less than AbbVie Inc. (46.36), less than Merck & Co., Inc. (142.24), less than Gilead Sciences, Inc. (169.22), less than Johnson & Johnson (9.20), less than Eli Lilly and Company (118.49), greater than Pfizer Inc. (-551.94), less than Amgen Inc. (43.56), less than Biogen Inc. (27.11),

CompanyPE RatioMarket cap
46.36$277.35B
142.24$327.97B
169.22$81.83B
9.20$353.71B
118.49$767.39B
-551.94$163.65B
43.56$164.06B
27.11$31.71B

Build a custom stock screener for Bristol-Myers Squibb Company (BMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bristol-Myers Squibb Company using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bristol-Myers Squibb Company (BMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bristol-Myers Squibb Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bristol-Myers Squibb Company's PE Ratio?

How is the PE Ratio calculated for Bristol-Myers Squibb Company (BMY)?

What is the highest PE Ratio for Bristol-Myers Squibb Company (BMY)?

What is the 3-year average PE Ratio for Bristol-Myers Squibb Company (BMY)?

What is the 5-year average PE Ratio for Bristol-Myers Squibb Company (BMY)?

How does the current PE Ratio for Bristol-Myers Squibb Company (BMY) compare to its historical average?